Augmented drug preferentially eliminates cancer cells but does not harm healthy cells

Digital transformation conceptual for next generation technology era

Johns Hopkins Medicine researchers have revamped an anti-cancer drug to better target cancer cells and leave healthy tissues unharmed. Scientists have dubbed this type of targeted approach a “prodrug” -; a medicine designed to release its payload in a particular area of the body and in no other areas.

Host your own online classes with this heavily discounted lifetime subscription

Previous article

Researchers may have found a new biomarker for acute COVID-19

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News